17,538 followers
A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice https://t.co/U51SAFPTwQ https://t.co/PnnaWWPons
A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice https://t.co/U51SAFPTwQ https://t.co/PnnaWWPons
RT @FrontImmunol: New Research: A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion t…
New Research: A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice: Atherosclerosis is a chronic inflammatory disease caused by deposition of oxidative… https://t.co/el2J